| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 04/15/2004 | WO2004030684A2 Kavalactone product |
| 04/15/2004 | WO2004030680A1 Pharmaceutical composition comprising bando deep ocean water of the concentrate thereof for treatment and prevention of liver disease |
| 04/15/2004 | WO2004030670A1 Potent inhibitor of hcv serine protease |
| 04/15/2004 | WO2004030662A1 Combination chemotherapy compositions and methods |
| 04/15/2004 | WO2004030656A1 Method of preparing pharmaceutical dosage forms containing multiple active ingredients |
| 04/15/2004 | WO2004030627A2 Synergistic methods and compositions for treating cancer |
| 04/15/2004 | WO2004030625A2 Synergistic methods and compositions for treating cancer |
| 04/15/2004 | WO2004030618A2 Methods and reagents for the treatment of diseases and disorders associated with increased levels of proinflammatory cytokines |
| 04/15/2004 | WO2004030448A1 RELATIONSHIP BETWEEN LIPOPROTEIN (a) AND ATHEROMA SCLEROSIS |
| 04/15/2004 | WO2004017962A3 Tropical formulation comprising at least 5% of metronidazole in white petrolatum and its use in the anal and rectal region |
| 04/15/2004 | WO2004010987A3 Use of s1p receptor agonists in heart diseases |
| 04/15/2004 | WO2004005262A3 New neuropeptide y y5 receptor antagonists |
| 04/15/2004 | WO2004004774A3 Compositions comprising panthetine for the treatment of dyslipidemia |
| 04/15/2004 | WO2004004689A8 Compositions and methods for amelioration of human female sexual dysfunction |
| 04/15/2004 | WO2004004451B1 Methods of screening compounds for grk6 modulating activity |
| 04/15/2004 | WO2004003545A9 Methods and compositions for inhibition of multi-drug resistance by hyaluronan oligomers |
| 04/15/2004 | WO2004000875A3 Novel kcnq polypeptides, modulators thereof, and their uses in the treatment of mental disorders |
| 04/15/2004 | WO2003103581A3 Compositions and methods for liver growth and liver protection |
| 04/15/2004 | WO2003101988A3 Compounds and compositions for the treatment of diabetes and diabetes-related disorders |
| 04/15/2004 | WO2003092603B1 Composition and method for reducing post-prandial blood glucose |
| 04/15/2004 | WO2003082392A3 Oxygenating agents for enhancing host responses to microbial infections |
| 04/15/2004 | WO2003066807A3 Method of inhibiting pathogenicity of infectious agents |
| 04/15/2004 | WO2003066064A3 Methods of resistant bacterial disease treatment using metal-complexed tetracycline antibiotics |
| 04/15/2004 | WO2003059951A3 Novel anti-igf-ir antibodies and uses thereof |
| 04/15/2004 | WO2003056899A9 Nitric oxide donors for treatment of disease and injury |
| 04/15/2004 | WO2003049723A8 Use of protease-activated receptor-2 inhibitor in the manifacture of a medicament for treating delayed hypersensitivity |
| 04/15/2004 | WO2003039449A3 Modulation of dopaminergic neurons |
| 04/15/2004 | WO2003026574A3 Methods and compositions to determine the chemosensitizing dose of suramin used in combination therapy |
| 04/15/2004 | WO2003022217A9 Treatment of excessive radiation (e.g. sunburn) exposure |
| 04/15/2004 | WO2003018823A8 Obesity related genes expressed at least in the hypotalamus, liver or pancreas |
| 04/15/2004 | WO2003006057A8 Composition and method for the treatment of disease |
| 04/15/2004 | WO2003004604A9 Phage displayed pdz domain ligands |
| 04/15/2004 | WO2003002756A9 Fkbp51/52 and cyp40-mediated mammalian hair growth |
| 04/15/2004 | WO2003002722A9 T cell regulatory genes and methods of use thereof |
| 04/15/2004 | WO2002062361A8 Antiviral composition containing propolis and essential oils |
| 04/15/2004 | WO2002055721A3 Modular transfection systems based on nucleoprotein filaments |
| 04/15/2004 | WO2002050090A8 Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
| 04/15/2004 | WO2002016553B1 Regulator gene and system useful for the diagnosis and therapy of osteoporosis |
| 04/15/2004 | WO2002009690A8 Pharmaceutical composition comprising a photochemotherapeutic agent and a mucoadhesive agent |
| 04/15/2004 | WO2001070955A8 Identification of essential genes in prokaryotes |
| 04/15/2004 | US20040073956 Assay techniques based on growth stage dependent expression inc. elegans |
| 04/15/2004 | US20040073280 Method of controlling body temperature while reducing shivering |
| 04/15/2004 | US20040073258 Body tissue and skin treatment method using pulsing heating pad and topical cream |
| 04/15/2004 | US20040073037 Anticholesterol agents; cardiovascular disorders; antiinflammatory agents; peroxisome proliferator activator receptor antagonist |
| 04/15/2004 | US20040073026 Cyclic protein tyrosine kinase inhibitors |
| 04/15/2004 | US20040073024 Phosphorus-containing compounds and uses thereof |
| 04/15/2004 | US20040073008 Recombinant poxvirus for chimeric proteins of the human immunodeficiency virus |
| 04/15/2004 | US20040072998 Comprises nucleotide sequences coding transient receptor proteins (TRP) for diagnosis, prevention and treatment of cell proliferative disorders; antitumor agents |
| 04/15/2004 | US20040072993 Identifying modulator of chimeric chaperone protein for treatment and diagnosis of immune, cell proliferative and infectious disorders |
| 04/15/2004 | US20040072903 Dyslipidemia therapy; antiischemic agents; prevent, delay cardiovascular disorders |
| 04/15/2004 | US20040072899 Antiinflammatory agents; antipyretics; analgesics |
| 04/15/2004 | US20040072897 Solvent extraction from plant using liquid carbon dioxide; therapy for muscular disorders |
| 04/15/2004 | US20040072894 Anticholesterol agents; compressed into tablets |
| 04/15/2004 | US20040072889 Method of using a COX-2 inhibitor and an alkylating-type antineoplastic agent as a combination therapy in the treatment of neoplasia |
| 04/15/2004 | US20040072885 Treatments for immune-mediated ear disorders |
| 04/15/2004 | US20040072883 Cyclooxygenase-2 selective inhibitors, compositions and methods of use |
| 04/15/2004 | US20040072880 Cycloalkyl inhibitors of potassium channel function |
| 04/15/2004 | US20040072868 Liver disorders; anticholesterol agents; cardiovascular disorders |
| 04/15/2004 | US20040072867 Antiemetics, antidepressants, anxiolytic agents, antitussive agents |
| 04/15/2004 | US20040072863 Novel quinuclidine derivatives and medicinal compositions containing the same |
| 04/15/2004 | US20040072854 Antiemetics; psychlogical disorders; antidepressants; anxiolytic agents; antitussive agents |
| 04/15/2004 | US20040072851 Incontinence; benign prostatic hyperplasia |
| 04/15/2004 | US20040072846 Pharmaceutical formulation containing thienopyrimidines and antithrombotics, calcium antagonists, prostaglandins or prostaglandin derivatives |
| 04/15/2004 | US20040072842 Difluorothioacetamides of oxazolidinones with a glycoloylpiperazine substituent |
| 04/15/2004 | US20040072832 Anticancer agents; antiinflammatory agents |
| 04/15/2004 | US20040072831 Reverse-turn mimetics and method relating thereto |
| 04/15/2004 | US20040072815 Antibiotic composition and method |
| 04/15/2004 | US20040072809 Antiinflammatory agents; analgesics; dilation; reducing pressure; therapy for vision defects |
| 04/15/2004 | US20040072808 Menopause; hormone replacement therapy; controlling dosage |
| 04/15/2004 | US20040072795 Complex of Dna and lipid with detectable label; accuracy positioning; anticancer agents, antiinflammatory agents |
| 04/15/2004 | US20040072792 Local anesthetic and agent for maintaining anesthetic action; acidic mucopolysaccharide or a cellulose derivative; does not contain a catecholamine; for oral surgery or dental treatment; sodium chondroitin sulfate; hydroxypropylmethylcellulose |
| 04/15/2004 | US20040072788 Nucleoside derivatives as inhibitors of RNA-dependent RNA viral polymerase |
| 04/15/2004 | US20040072780 Methods for obtaining inhibitors of tirc7 ligand binding and uses thereof |
| 04/15/2004 | US20040072773 Novel functions for dp214 |
| 04/15/2004 | US20040072772 Survival Regulating Kinase, SRK, involved in cell signal transduction; method of detecting a protein kinase activity in a human SRK polypeptide |
| 04/15/2004 | US20040072766 Bioassay for screening an inhibitor or activator of phosphatidylinositol 3-kinase, finding immunostimulants, or immunosuppressants |
| 04/15/2004 | US20040072760 Synergistic methods and compositions for treating cancer |
| 04/15/2004 | US20040072759 Polypeptides |
| 04/15/2004 | US20040072732 Inhibiting relapse of antibiotic-associated diarrhea in a patient by administering ramoplanin in an amount and for a duration effective to inhibit relapse of antibiotic associated diarrhea in the patient |
| 04/15/2004 | US20040072297 Comprises maternal protein (MATER) for treatment of infertility and reduced fertility; contraceptives |
| 04/15/2004 | US20040072264 Comprises nucleotide sequences coding ca protein (CAP) for diagnosing and treating cell proliferative disorders; antiproliferative agents |
| 04/15/2004 | US20040072258 Disruption of a Ras-protein complex by a Ras antagonist, e.g.,farensylthiosalicylic acid, analyzed; identifying drug candidates inhibiting aberrant Ras activity; binding andinactivating mRNA of anchor protein by a oligonucleotides |
| 04/15/2004 | US20040072220 Neurotonin and use thereof |
| 04/15/2004 | US20040072206 Screening for enzyme inhibitor to prevent microorganismal propagation; bactericides; antibiotic |
| 04/15/2004 | US20040072189 Diagnosing cancer via presence of osteopontin in epithelial cells; genetic vaccines; antitumor agents |
| 04/15/2004 | US20040072177 Novel human serine-threonine kinase |
| 04/15/2004 | US20040072171 Screening for regulatory factors of neurofibromatosis (NF2); antitumor agents |
| 04/15/2004 | US20040072170 Using creatine kinase messenger RNA expression profiles to diagnose congestive heart failure |
| 04/15/2004 | US20040072169 Comprises nucleotide sequences coding polypeptide for exogenous expression in avian embryonic stem cells; bioreactors |
| 04/15/2004 | US20040072168 Novel deoxynucleoside kinase enzyme variants |
| 04/15/2004 | US20040072154 Novel compositions and methods for cancer |
| 04/15/2004 | US20040072146 Using peptide modulator to prevent associations between adenine nucleotide translocator (ANT) and viral replication proteins (VPR); antiapoptosis |
| 04/15/2004 | US20040071794 Administering methysticin, dihydromethysticin, desmethoxyyangonin, yangonin, dihydrokavain, and/or kavain as drug intensifier |
| 04/15/2004 | US20040071793 Oral rehydration methods and compositions |
| 04/15/2004 | US20040071774 Methods for treating ovarian cancer, poly (phosphoester) compositions, and biodegradable articles for same |
| 04/15/2004 | US20040071770 Free radical scavenging liposome containing mixture of beta-carotene, vitamin E, vitamin C, glutathione, niacin, and/or trace metal; quenching |
| 04/15/2004 | US20040071768 Compositions and methods for treating cancer |
| 04/15/2004 | US20040071766 Methods of treating vascular diseases characterized by nitric oxide insufficiency |
| 04/15/2004 | US20040071749 DNA or protein biosynthesis in dermal cells; topically applied |
| 04/15/2004 | US20040071711 Imaging, diagnosis and treatment of disease |